4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-002617
Chief Executive Officer acquired 11,806 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2022-01-07 | Option exercise | +11,806 | $5.19 | $61,273 | 4,057,634 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2022-01-07 | Option exercise · Stock Option (right to buy Common Stock) | −11,806 | 761,421 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…